Saturday, January 31, 2026

Bio-Revolution: Celltrion’s $700M Biosimilar Is Reshaping the Global Drug Market

Celltrion's breakthrough in antibody biosimilars is transforming healthcare, enhancing access and innovation in treatment options.

KAMCO Attains Top Safety Rating in Public Agency Evaluation

KAMCO (Korea Asset Management Corporation) announced on...

Historic Korean Legation in D.C. Set to Become National Landmark

The U.S. federal government announced yesterday that it would list the Korean Legation in Washington, D.C., as a U.S. National Historic Site.

Tag: NK cell therapy

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

NK Cell Cancer Therapies Move Closer to Market as Matica BioLabs Partners With Ingenium

CHA Biotech's Matica BioLabs partners with Ingenium Therapeutics for NK cell therapy production, targeting cancer treatment advancements.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.